Recent data from Howell's lab demonstrated that two P-type of ATPases ATP7A and ATP7B are involved in cisplatin resistance in human ovarian carcinoma cells by modulating cellular pharmacology of cisplatin and other metals, suggesting that a sequestration and secretory system may exist (Katano et al, 2002, 2003). Here, ATP7A is linked to ovarian carcinoma.